BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8354190)

  • 1. Environmentally related cancer in women.
    Environ Health Perspect; 1993 Jun; 101(2):110-1. PubMed ID: 8354190
    [No Abstract]   [Full Text] [Related]  

  • 2. Risks of breast, endometrial, and ovarian cancers after twin births.
    Ji J; Försti A; Sundquist J; Hemminki K
    Endocr Relat Cancer; 2007 Sep; 14(3):703-11. PubMed ID: 17914100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine cancer risks for women during the perimenopause and beyond.
    Leslie KK; Kumar NS
    Semin Reprod Endocrinol; 1999; 17(4):359-70. PubMed ID: 10851575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Obesity and risk of cancer in the woman].
    Schindler AE
    Zentralbl Gynakol; 1998; 120(5):235-40. PubMed ID: 9629630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
    Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
    Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infertility as a cancer risk factor - a review.
    Cetin I; Cozzi V; Antonazzo P
    Placenta; 2008 Oct; 29 Suppl B():169-77. PubMed ID: 18790330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian stimulation: is there a long-term risk for ovarian, breast and endometrial cancer?
    Lerner-Geva L; Rabinovici J; Lunenfeld B
    Womens Health (Lond); 2010 Nov; 6(6):831-9. PubMed ID: 21118041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonbreast second malignancies after treatment of primary breast cancer.
    Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor R; Kumar R
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1489-92. PubMed ID: 18804919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial cancer with concurrent ovarian malignancy: assessing the risks.
    Goodman A
    Obstet Gynecol; 2005 Oct; 106(4):680-1. PubMed ID: 16199620
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of oral contraceptives and risk of cancer].
    Bjørge T; Engeland A
    Tidsskr Nor Laegeforen; 2002 Aug; 122(18):1788-90. PubMed ID: 12362690
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of IGF I in gynecology and obstetrics].
    Bettahar-Lebugle K; Ohl J; Moreau L; Dellenbach P
    Contracept Fertil Sex; 1995 May; 23(5):302-6. PubMed ID: 7613575
    [No Abstract]   [Full Text] [Related]  

  • 13. [Risk factors for the development of malignant neoplasms of the reproductive organs in women].
    Maksimov SIa; Guseĭnov KD; Kosnikov AG; Antoneeva II; Khadzhimba AS
    Vopr Onkol; 2003; 49(4):496-501. PubMed ID: 14569945
    [No Abstract]   [Full Text] [Related]  

  • 14. Timing of pregnancy and the risk of epithelial ovarian cancer.
    Whiteman DC; Siskind V; Purdie DM; Green AC
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What's new in hormone replacement therapy of postmenopausal women? II. Risks of hormone replacement therapy (HRT)].
    Martin-Du Pan RC; Luzuy F
    Rev Med Suisse Romande; 2000 Jun; 120(6):523-7. PubMed ID: 11014097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer.
    Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2304-13. PubMed ID: 18006919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. For women on hormone therapy, other options may be safer.
    Brink S
    US News World Rep; 2000 Feb; 128(5):58. PubMed ID: 11184138
    [No Abstract]   [Full Text] [Related]  

  • 20. Endometrial cancer in patients with breast carcinoma treated with tamoxifen: report of two cases and the literature overview.
    Sliwińska M; Wojtacki J; Sliwiński W
    Med Sci Monit; 2000; 6(2):399-406. PubMed ID: 11208346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.